These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29683225)

  • 1. Utility of routine electrocardiographic screening before initiation of propranolol for infantile hemangiomas.
    Lund EB; Chamlin SL; Mancini AJ
    Pediatr Dermatol; 2018 Jul; 35(4):e233-e234. PubMed ID: 29683225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Routine Electrocardiography Necessary Before Initiation of Propranolol for Treatment of Infantile Hemangiomas?
    Yarbrough KB; Tollefson MM; Krol AL; Leitenberger SL; Mann JA; MacArthur CJ
    Pediatr Dermatol; 2016 Nov; 33(6):615-620. PubMed ID: 27599450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is cardiovascular evaluation necessary prior to and during beta-blocker therapy for infantile hemangiomas?: A cohort study.
    Raphael MF; Breugem CC; Vlasveld FA; de Graaf M; Slieker MG; Pasmans SG; Breur JM
    J Am Acad Dermatol; 2015 Mar; 72(3):465-72. PubMed ID: 25592625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac diagnostics before oral propranolol therapy in infantile hemangioma: retrospective evaluation of 234 infants.
    Frongia G; Byeon JO; Arnold R; Mehrabi A; Günther P
    World J Pediatr; 2018 Jun; 14(3):254-258. PubMed ID: 29796952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac screening in infants with infantile hemangiomas before propranolol treatment.
    Blei F; McElhinney DB; Guarini A; Presti S
    Pediatr Dermatol; 2014; 31(4):465-70. PubMed ID: 24889812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of infantile hemangiomas with beta-blockers: a review.
    Shah S; Frieden IJ
    Skin Therapy Lett; 2013; 18(6):5-7. PubMed ID: 24305730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of poor response to oral propranolol in infantile hemangiomas.
    Hali F; Moubine I; Berrami H; Serhier Z; Othmani MB; Chiheb S
    Arch Pediatr; 2023 Oct; 30(7):455-457. PubMed ID: 37394367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol induced hypoglycemia.
    Horev A; Haim A; Zvulunov A
    Pediatr Endocrinol Rev; 2015 Mar; 12(3):308-10. PubMed ID: 25962208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety assessment during initiation and maintenance of propranolol therapy for infantile hemangiomas.
    Babiak-Choroszczak L; Giżewska-Kacprzak K; Dawid G; Gawrych E; Bagłaj M
    Adv Clin Exp Med; 2019 Mar; 28(3):375-384. PubMed ID: 30659785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas.
    Hu L; Zhou B; Huang H; Chang L; Qiu Y; Ma G; Chen H; Jin Y; Xu X; Lin X; Li W
    J Dermatol; 2016 Oct; 43(10):1160-1166. PubMed ID: 26945921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propranolol as the first-line therapy for infantile hemangiomas: preliminary results of two centers.
    Celik A; Tiryaki S; Musayev A; Kismali E; Levent E; Ergun O
    J Drugs Dermatol; 2012 Jul; 11(7):808-11. PubMed ID: 22777220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
    López-Gutiérrez JC
    Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants.
    de Graaf M; Breur JMPJ; Raphaël MF; Vos M; Breugem CC; Pasmans SGMA
    J Am Acad Dermatol; 2011 Aug; 65(2):320-327. PubMed ID: 21601311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.
    Erbay A; Sarialioglu F; Malbora B; Yildirim SV; Varan B; Tarcan A; Gülcan H; Demir S; Derbent M; Uslu N; Abbasoğlu A
    Turk J Pediatr; 2010; 52(5):450-6. PubMed ID: 21434528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In brief: oral propranolol infantile hemangiomas.
    Med Lett Drugs Ther; 2011 Oct; 53(1376):88. PubMed ID: 22033213
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of infantile hemangiomas-experience of a tertiary hospital.
    Gomes R; Salazar L; Fraga C; Correia MR; Barbosa-Sequeira J; Fernandes A; Álvares S; Banquart Leitão J; Paiva Coelho M
    Eur J Pediatr; 2023 Apr; 182(4):1611-1618. PubMed ID: 36705724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of propranolol therapy in Moroccan children with infantile hemangioma.
    Lahrichi A; Hali F; Baline K; Fatoiki FZE; Chiheb S; Khadir K
    Arch Pediatr; 2018 Nov; 25(8):449-451. PubMed ID: 30361087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chinese experts consensus on the use of oral propranolol for treatment of infantile hemangiomas].
    Zheng JW; Wang XK; Qin ZP; Fan XD; Li K; Yang YW; Huo R; Liu SH; Zhao JH; Wang XY; Zhou DK
    Shanghai Kou Qiang Yi Xue; 2016 Jun; 25(3):257-60. PubMed ID: 27609372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma.
    Denoyelle F; Leboulanger N; Enjolras O; Harris R; Roger G; Garabedian EN
    Int J Pediatr Otorhinolaryngol; 2009 Aug; 73(8):1168-72. PubMed ID: 19481268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
    Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
    J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.